These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31787357)

  • 1. Conjugable A
    Federico S; Margiotta E; Moro S; Kozma E; Gao ZG; Jacobson KA; Spalluto G
    Eur J Med Chem; 2020 Jan; 186():111886. PubMed ID: 31787357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
    Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G
    Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
    Venkatesan G; Paira P; Cheong SL; Vamsikrishna K; Federico S; Klotz KN; Spalluto G; Pastorin G
    Bioorg Med Chem; 2014 Mar; 22(5):1751-65. PubMed ID: 24518296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.
    Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G
    Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A
    Federico S; Persico M; Trevisan L; Biasinutto C; Bolcato G; Salmaso V; Da Ros T; Gianferrara T; Prencipe F; Kachler S; Klotz KN; Pacor S; Moro S; Spalluto G
    ChemMedChem; 2023 Nov; 18(21):e202300299. PubMed ID: 37675643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazolo[4,3-
    Federico S; Margiotta E; Paoletta S; Kachler S; Klotz KN; Jacobson KA; Pastorin G; Moro S; Spalluto G
    Medchemcomm; 2019 Jul; 10(7):1094-1108. PubMed ID: 31391881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human a(3) adenosine receptor antagonists.
    Federico S; Ciancetta A; Sabbadin D; Paoletta S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    J Med Chem; 2012 Nov; 55(22):9654-68. PubMed ID: 23098605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
    Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.
    Vernall AJ; Stoddart LA; Briddon SJ; Ng HW; Laughton CA; Doughty SW; Hill SJ; Kellam B
    Org Biomol Chem; 2013 Sep; 11(34):5673-82. PubMed ID: 23881285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists.
    Redenti S; Ciancetta A; Pastorin G; Cacciari B; Moro S; Spalluto G; Federico S
    Curr Top Med Chem; 2016; 16(28):3224-3257. PubMed ID: 27150365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors.
    Salmaso V; Persico M; Da Ros T; Spalluto G; Kachler S; Klotz KN; Moro S; Federico S
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists.
    Baraldi PG; Baraldi S; Saponaro G; Aghazadeh Tabrizi M; Romagnoli R; Ruggiero E; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2015 Jul; 58(13):5355-60. PubMed ID: 26046697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A
    Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V
    Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies.
    Catarzi D; Colotta V; Varano F; Poli D; Squarcialupi L; Filacchioni G; Varani K; Vincenzi F; Borea PA; Dal Ben D; Lambertucci C; Cristalli G
    Bioorg Med Chem; 2013 Jan; 21(1):283-94. PubMed ID: 23171656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Covalent, Clickable Probes for Adenosine A
    Trinh PNH; Chong DJW; Leach K; Hill SJ; Tyndall JDA; May LT; Vernall AJ; Gregory KJ
    J Med Chem; 2021 Jun; 64(12):8161-8178. PubMed ID: 34120444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors.
    Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    Eur J Med Chem; 2016 Jan; 108():529-541. PubMed ID: 26717203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.